Zenith® LP Abdominal Aortic Aneurysm (AAA) Post-Market Registry
NCT ID: NCT01424267
Last Updated: 2012-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
76 participants
OBSERVATIONAL
2010-07-31
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Zenith® Low Profile AAA Endovascular Graft
Treatment of an abdominal aortic or aorto-iliac aneurysm with the CE-marked Zenith(R) Low Profile AAA Endovascular Graft.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zenith® Low Profile AAA Endovascular Graft
Treatment of an abdominal aortic or aorto-iliac aneurysm with the CE-marked Zenith(R) Low Profile AAA Endovascular Graft.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cook Group Incorporated
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AKH (General Hospital Vienna)
Vienna, , Austria
UHZ Hamburg GmbH (Eppendorf University Hospital)
Hamburg, , Germany
Klinikum rechts der Isar (RDI Munich)
Munich, , Germany
Klinikum Nürnberg Süd
Nuremberg, , Germany
Royal Victoria Hospital
Belfast, , Ireland
Nuovo Ospendale Civile Sant' Agostino Estense di Baggiovara
Modena, , Italy
Azoemda ospedaliera San Camillo Forlanini
Rome, , Italy
Catharina Ziekenhuis
Eindhoven, , Netherlands
Maastricht University Medical Center
Maastricht, , Netherlands
St. Olav University Hospital
Trondheim, , Norway
Guy's and St. Thomas' Hospital
London, , United Kingdom
St. Mary's Hospital
London, , United Kingdom
Manchester Royal Informary
Manchester, , United Kingdom
Freeman Hospital
Newcastle upon Tyne, , United Kingdom
Royal Gwent Hospital
Wales, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10-006
Identifier Type: -
Identifier Source: org_study_id